wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36449367-66AD2776-72DF-4E88-B215-D105F6856B2D
Q36449367-66AD2776-72DF-4E88-B215-D105F6856B2D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36449367-66AD2776-72DF-4E88-B215-D105F6856B2D
Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer.
P2860
Q36449367-66AD2776-72DF-4E88-B215-D105F6856B2D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36449367-66AD2776-72DF-4E88-B215-D105F6856B2D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
110304631b05ccfe9d69e47a54b5d1a5c12f51ed
P2860
Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.